The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Share News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.75
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.50 (2.857%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 17.75
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS AND TRADING: Victorian Plumbing profit up; Duke revenue dips

Wed, 22nd Nov 2023 14:15

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Tremor International Ltd - Israel-headquartered company offering an end-to-end technology advertising platform - Says revenue in the third quarter of the year grew 13% to USD80.1 million from USD70.9 million the year prior. Nevertheless, swings to pretax loss to USD4.04 million from a USD3.50 million profit the year before. Operating costs increase 33% to USD69.8 million from USD52.7 million. Looking ahead, it says ongoing uncertainty will limit customer spending through to the rest of 2023. Expects approximately between USD80 million and USD85 million in adjusted earnings before interest, tax, depreciation and amortisation for the full year.

----------

Rockwood Strategic PLC - London-based investor in smaller UK public companies, formerly known as Rockwood Realisation PLC - Says net asset value per share at September 30 was 1,851.62 pence, down from 1,959.56p at March 31. NAV total return in six months to September 30 was negative 5.5%, compared to a decline in the FTSE AIM All Share Index of negative 10.3%. Chair Noel Lamb says: "The first half of our financial year has been a challenging one for UK small company stock market investors, with sustained outflows from the asset class amidst negative sentiment as interest rates continued to rise against a subdued economic backdrop. For those with sensible time horizons, these are typically the conditions for positive future medium-term returns, not least due to the heavily depressed valuations of small company shares relative to history. Private equity and trade buyers are clearly recognising the opportunities created by this environment, with the drumbeat of takeovers within Rockwood's portfolio continuing throughout 2023. We are delighted that during the period, the long-standing share price discount to Net Asset Value was closed, and we were able to grow our shareholder base."

----------

Victorian Plumbing Group PLC - Lancashire, England-based bathroom retailer - Says pretax profit in the year ended September 30 grows 32% GBP15.6 million from GBP11.8 million a year prior as revenue rises 5.8% to GBP285.1 million from GBP269.4 million the year before. Proposes a final dividend of 0.95 pence per share, bringing the total dividend to 1.40p per share, up 73% from 1.10p the year before. Looking ahead, it says it is "confident" in future growth prospects. Chief Executive Officer Mark Radcliffe says: "As a highly cash generative business with a strong balance sheet, we continue to invest in the business - across people, technology and infrastructure. Our new purpose-built 544,000 square feet distribution centre, once operational, will enable further growth in the core bathroom category, as well as unlocking further strategic category expansion. We are confident that Victorian Plumbing's profitable growth strategy will continue to deliver long-term value to all stakeholders."

----------

Duke Royalty Ltd - Guernsey-based provider of royalty finance to companies in UK and Europe - Says total revenue for the half year ended September 30 falls 66% to GBP10.4 million from GBP31.0 million the year before. Recurring cash revenue totalled GBP12.2 million, up 17% from GBP10.4 million in the first half of financial 2023. Pretax profit stoops by 81% to GBP3.8 million from GBP20.4 million a year prior. Maintains its quarterly dividend of 0.70 pence per share. Looking ahead, says it is "well-positioned" for growth. Chair Nigel Birrell comments: "During the interim period, Duke was able to post its twelfth consecutive quarter of increasing recurring cash revenue, which was a fantastic achievement for the company. In line with this strong financial performance, the company also maintained its quarterly dividend of 0.70p per share. Investors can be reassured that the dividend payout remains well covered by operating cashflow, with the attractive yield representing a pillar of Duke's ongoing business model and its overall financial discipline."

----------

Atlantic Lithium Ltd - Sydney-based lithium exploration and development company, with assets in Ghana and Ivory Coast - Says beginning of construction of Ewoyaa lithium project in Ghana will begin in late 2024, with initial production expected in early 2025. CEO Keith Muller says: "Being now within only two years from initial production, the company continues to actively recruit experienced individuals to bolster the expertise of the leadership team ahead of mine build and operation, while also ensuring a successful transition to becoming a lithium producer. We are delighted to welcome three general managers to the team, each bringing significant expertise from across the mining sector. We expect to continue to grow our teams, both in Ghana and in Australia, as we near construction."

----------

OptiBiotix Health PLC - York, England-based life sciences company - Wins grant from the University of Reading for research of its prebiotic and mineral complex, WellBiome. Says the study will assess Well Biome's impact on the gut microbiome. CEO Stephen O'Hara says: "The award of this grant to investigate WellBiome's impact on the gut microbiome throughout its length is another step in OptiBiotix's strategy of developing science based functional ingredients which modify the human microbiome to improve health. Consumer understanding and interest in the microbiome and the role of gut health in general health and wellbeing is growing rapidly, particularly in the US, and this is creating a market opportunity that is large and expanding."

----------

By Sabrina Penty, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
28 Feb 2022 14:24

OptiBiotix Health ends year in line with expectations

(Sharecast News) - OptiBiotix Health updated the market on its trading ahead of its final results on Monday, reporting total invoiced sales of £2.2m in 2021 - an increase of 46.7% year-on-year, and in line with market expectations.

Read more
9 Feb 2022 18:13

TRADING UPDATES: Chaarat Gold beats guidance for 2021 Kapan output

TRADING UPDATES: Chaarat Gold beats guidance for 2021 Kapan output

Read more
9 Feb 2022 11:56

OptiBiotix lays out strategy for investment and growth

(Sharecast News) - Life sciences company OptiBiotix Health updated the market on its strategic and commercial progress on Wednesday, reporting that the next phase of its strategy would involve reinvesting proceeds from the recent sale of SkinBioTherapeutics shares, which generated £2m.

Read more
18 Jan 2022 21:27

TRADING UPDATES: Biffa chair responds to shareholders; Kromek improves

TRADING UPDATES: Biffa chair responds to shareholders; Kromek improves

Read more
5 Jan 2022 15:31

OptiBiotix receives British Retail Consortium accreditation

OptiBiotix receives British Retail Consortium accreditation

Read more
15 Dec 2021 22:09

IN BRIEF: OptiBiotix Health signs supply deal in Saudi Arabia

IN BRIEF: OptiBiotix Health signs supply deal in Saudi Arabia

Read more
15 Dec 2021 14:45

OptiBiotix signs supply deal with Saudi Arabia chemist chain

(Sharecast News) - Life sciences company OptiBiotix Health has signed an exclusive supply agreement with pharmacy chain Nahdi Medical, it announced on Wednesday, for the sales of its 'GoFigure' and 'SlimBiome Medical' weight management products in Saudi Arabia.

Read more
9 Dec 2021 15:37

OptiBiotix signs deal with massive chemist chain in India

(Sharecast News) - OptiBiotix Health said on Thursday that its India subsidiary has signed an exclusive sales agreement with one of the leading hospital and pharmacy chains in the country, Apollo Hospitals Enterprises, for the sale of its 'GoFigure' weight management product range in India.

Read more
1 Dec 2021 19:27

TRADING UPDATES: Peel Hunt revenue tanks; Marlowe reaffirms guidance

TRADING UPDATES: Peel Hunt revenue tanks; Marlowe reaffirms guidance

Read more
17 Nov 2021 19:36

TRADING UPDATES: 3i Infrastructure opens USD512 million investment

TRADING UPDATES: 3i Infrastructure opens USD512 million investment

Read more
17 Nov 2021 10:56

OptiBiotix Health forms operating subsidiary in India

(Sharecast News) - Life sciences company OptiBiotix Health announced the formation of its new India subsidiary OptiBiotix Health India (OHI) on Wednesday.

Read more
25 Oct 2021 10:49

IN BRIEF: OptiBiotix Health says SlimBiome approved by Health Canada

IN BRIEF: OptiBiotix Health says SlimBiome approved by Health Canada

Read more
30 Sep 2021 15:45

EARNINGS UPDATES: Northbridge "delighted"; Echo Energy loss narrows

EARNINGS UPDATES: Northbridge "delighted"; Echo Energy loss narrows

Read more
1 Sep 2021 15:46

Director dealings: Optibiotix CEO ups stake

(Sharecast News) - Optibiotix Health revealed on Wednesday that chief executive René Kamminga had purchased 8,188 ordinary shares in the AIM-listed life sciences firm.

Read more
10 Aug 2021 19:24

TRADING UPDATES: Barkby expects revenue growth; Beeks trading in line

TRADING UPDATES: Barkby expects revenue growth; Beeks trading in line

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.